Home›Articles›How the PRESENT trial ended the NeuVax vaccine programArticleHow the PRESENT trial ended the NeuVax vaccine programArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnNeuVax, Drugs and Medicinal Substances Well-attested SourcesGalena Biopharma Discontinues NeuVax (nelipepimut-S) Phase 3 PRESENT (Clinical Leader, 2016)Press releaseQuote, Press releaseOn June 27, 2016, the IDMC recommended that the PRESENT trial be stopped due to futility.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.